The idea of Modern Medtech Park in Delhi germinates

Delhi’s Industry Minister sounded amenable, signals west Delhi as site

New Delhi: Modern Medical Device Manufacturing Cluster in Delhi may become a reality in foreseeable future. The Surgical Manufacturers & Traders Association (SMTA) gets a very positive nod from Industries Minister Sardar Manjinder Singh Sirsa in an event in Delhi. This will be godsend for manufacturing units in Lal Dora and unorganized slums.

Rajiv Nath, one of greatest champions of Make in India in Medical Device Domain, feels modern medtech park in Delhi is the need of the hour. Managing Director of Hindustan Syringes (HMD), a scintillating success story in syringe making, Mr Nath calling HMD a proud member of SMTA, is very optimistic about its prospect because of late he finds Union government very proactively promoting Make in India. Mr Nath, also forum coordinator of Association of Indian Medical Device Industry (AiMeD) not long ago, was prolific in praise for the government for ensuring level playing field for domestic medical device manufactures vis a vis foreign manufacturers.

Rajiv Nath in talk with Medicare News said, “Existing Delhi based medical devices units making surgical instruments, stethoscopes, or rehabilitation orthopaedic aids etc need to relocate n expand n b compliant to evolving regulatory requirements under MDR n pollution n factory Act norms for which a modern medical device cluster supporting infrastructure is needed as existence in Lal Dora n unorganised slums is threatened.”

Mr Nath further said, “The Industry Minister was kindly very empathetic to the needs n offered promptly pragmatic solutions- hopefully the idea of a Medtech Park in west Delhi will germinate into a tangible development in very near future to enable MakeinIndia n MakeinDelhi to stem the tide of UnmakeinDelhi n entrepreneurs being pushed out of Delhi”

Related Posts

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Drug Controller Ajay Phatak said that the Bupivacaine Hydrochloride in Dextrose, manufactured by Themis Medicare Limited, Batch No. BKP02601 has been restricted for sale and use. The Rajasthan Drug…

Raj orders statewide inspection of blood centres for compliance with safety norms

Jaipur: Rajasthan’s Health Department, Wednesday, ordered intensified inspections of all govt, non-govt and private blood centres after repeated violations of safety and operational norms. Recent inspections led to suspension of 69 licences…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Raj orders statewide inspection of blood centres for compliance with safety norms

Raj orders statewide inspection of blood centres for compliance with safety norms

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

Telangana bets big on drug discovery hub

Telangana bets big on drug discovery hub

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery